AHR250117P30000
- 3.20
- 0.000.00%
American Healthcare REIT Newsroom
Truist Securities Adjusts American Healthcare REIT Price Target to $30 From $29, Maintains Buy Rating
Truist Financial Maintains American Healthcare REIT(AHR.US) With Buy Rating, Raises Target Price to $30
American Healthcare REIT Announces Dates for Fourth Quarter 2024 Earnings Release and Conference Call
Morgan Stanley Maintains American Healthcare REIT(AHR.US) With Buy Rating, Raises Target Price to $36
Morgan Stanley Maintains American Healthcare REIT(AHR.US) With Buy Rating, Maintains Target Price $29
American Healthcare REIT Is Maintained at Overweight by Morgan Stanley
American Healthcares Analyst Ratings
Morgan Stanley Maintains American Healthcare REIT(AHR.US) With Buy Rating, Raises Target Price to $29
2 Healthcare REIT Stocks to Buy Before Moving Into 2025
The Comeback of REITs: Top Ways to Play Commercial Real Estate
American Healthcare REIT To Go Ex-Dividend On December 31st, 2024 With 0.25 USD Dividend Per Share
American Healthcare REIT Keeps Quarterly Distribution at $0.25 a Share, Payable Around Jan. 17 to Holders of Record on Dec. 31
Press Release: American Healthcare REIT Declares Fourth Quarter 2024 Distribution
These Are the Best REITs to Own in 2025, Says KeyBanc -- Barrons.com
Chewy and XPO Are New Additions to BofA's List of Favorite Stocks
What Makes American Healthcare REIT (AHR) a New Strong Buy Stock
KeyBanc Raises Price Target on American Healthcare REIT to $35 From $28, Keeps Overweight Rating
BofA Securities Maintains American Healthcare REIT(AHR.US) With Buy Rating
NYSE New 52-Week Highs And Lows
Are Options Traders Betting on a Big Move in American Healthcare (AHR) Stock?